ArticleArtificial organs2026
Failure of Tricuspid Bioprosthetic Valve After Concomitant Use With a Continuous Flow Temporary Right Heart Pump.
Article in Artificial organs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Managing right ventricular heart failure (RVHF) is a challenging issue, requiring balancing volume status, increasing right ventricular (RV) contractility, and reducing RV afterload. When RVHF is refractory to medical management, surgical intervention is required. Current studies have documented the success of Impella RP for RVHF. However, there are no reports regarding the concomitant implantation of an Impella RP and a bioprosthetic tricuspid valve. A 79-year-old man presented with a pseudoaneurysm of the left atrioventricular junction. On physical exam he had 4+ diffuse pitting edema and ascites. Transesophageal echo (TEE) confirmed the presence of the pseudoaneurysm while also showing severe right ventricular systolic dysfunction, severe tricuspid regurgitation, dilated right and left atriums, with preserved left ventricular systolic function. Due to the poor function of the right ventricle, it was decided to repair the pseudoaneurysm, replace the tricuspid valve, and place an Impella RP flex. While mechanical circulatory support is an option for patients with RVHF, there is a risk of tricuspid valve damage, particularly in patients who have a concomitant bioprosthetic tricuspid valve replacement. Therefore, other MCS strategies could be more useful in RVHF patients who have a newly implanted bioprosthetic valve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.